Canada · Delayed Price · Currency is CAD MindBio Therapeutics Statistics
Total Valuation
CSE:MBIO has a market cap or net worth of CAD 3.42 million. The enterprise value is 7.82 million.
| Market Cap | 3.42M |
| Enterprise Value | 7.82M |
Important Dates
The last earnings date was Wednesday, October 29, 2025.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:MBIO has 684.80 million shares outstanding. The number of shares has decreased by -40.06% in one year.
| Current Share Class | 684.80M |
| Shares Outstanding | 684.80M |
| Shares Change (YoY) | -40.06% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 8.92% |
| Owned by Institutions (%) | n/a |
| Float | 623.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -6.06 |
| PB Ratio | -0.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.35 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.05 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -364.90% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 18.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.71% in the last 52 weeks. The beta is -0.37, so CSE:MBIO's price volatility has been lower than the market average.
| Beta (5Y) | -0.37 |
| 52-Week Price Change | -85.71% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 570,512 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:MBIO had revenue of CAD -565,340 and -1.46 million in losses. Loss per share was -0.01.
| Revenue | -565,340 |
| Gross Profit | -565,340 |
| Operating Income | -954,812 |
| Pretax Income | -1.47M |
| Net Income | -1.46M |
| EBITDA | n/a |
| EBIT | -954,812 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 12,777 in cash and 4.46 million in debt, giving a net cash position of -4.45 million or -0.01 per share.
| Cash & Cash Equivalents | 12,777 |
| Total Debt | 4.46M |
| Net Cash | -4.45M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -5.44M |
| Book Value Per Share | -0.03 |
| Working Capital | -5.16M |
Cash Flow
| Operating Cash Flow | -274,518 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 168.89% |
| Pretax Margin | 259.52% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:MBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 40.06% |
| Shareholder Yield | 40.06% |
| Earnings Yield | -42.72% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:MBIO has an Altman Z-Score of -583.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -583.87 |
| Piotroski F-Score | 1 |